Eva Harris Selected Research

Eva Harris Research Topics

Disease

116	Infections 04/2024 - 12/2002
85	Dengue (Dengue Fever) 04/2024 - 12/2002
27	Zika Virus Infection 01/2022 - 08/2016
18	Severe Dengue 01/2022 - 09/2007
10	COVID-19 12/2022 - 01/2021
10	Virus Diseases (Viral Diseases) 01/2022 - 12/2002
7	Fever (Fevers) 01/2020 - 08/2010
6	Yellow Fever 06/2023 - 03/2006
6	Flavivirus Infections 01/2022 - 12/2002
5	Human Influenza (Influenza) 01/2023 - 11/2009
5	Shock 01/2022 - 08/2009
4	Coinfection 05/2017 - 09/2010
3	Japanese Encephalitis 05/2022 - 01/2018
3	Microcephaly 01/2021 - 11/2017
2	Convalescence 10/2023 - 01/2018
2	Inflammation (Inflammations) 10/2023 - 01/2022
2	Leukopenia 01/2020 - 01/2012
2	Exanthema (Rash) 01/2020 - 01/2012
2	Headache (Headaches) 01/2020 - 01/2012
2	Pain (Aches) 01/2020 - 01/2012
2	Vomiting 01/2020 - 01/2012
2	Arthralgia (Joint Pain) 01/2020 - 01/2012
2	Myalgia 01/2020 - 01/2012
2	Guillain-Barre Syndrome 01/2019 - 01/2018
2	Hemorrhage 06/2017 - 01/2015
2	Mosquito-Borne Diseases 06/2013 - 12/2002
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Pneumonia (Pneumonitis) 01/2021
1	Congenital Abnormalities (Deformity) 01/2021
1	Rickettsia Infections 01/2021
1	Sepsis (Septicemia) 01/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Atherosclerosis 01/2021
1	Respiratory Syncytial Virus Infections 01/2020
1	Apnea 01/2020

Drug/Important Bio-Agent (IBA)

47	AntibodiesIBA 11/2023 - 03/2003
44	VaccinesIBA 04/2024 - 07/2009
31	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2005
18	Neutralizing AntibodiesIBA 01/2024 - 01/2011
15	Immunoglobulin G (IgG)IBA 04/2024 - 02/2004
15	Immunoglobulin M (IgM)IBA 01/2021 - 03/2003
12	Dengue VaccinesIBA 04/2024 - 01/2013
12	EnzymesIBA 01/2022 - 07/2005
12	Antiviral Agents (Antivirals)IBA 10/2021 - 12/2002
11	ImmunosorbentsIBA 01/2022 - 07/2005
10	EpitopesIBA 01/2021 - 09/2010
10	AntigensIBA 01/2021 - 08/2004
10	RNA (Ribonucleic Acid)IBA 01/2020 - 12/2002
9	CytokinesIBA 10/2023 - 06/2005
9	InterferonsIBA 06/2016 - 03/2004
8	Monoclonal AntibodiesIBA 08/2017 - 02/2010
7	Immune Sera (Antisera)IBA 01/2022 - 01/2013
7	Peptides (Polypeptides)IBA 01/2018 - 08/2004
6	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 06/2007
5	Glycoproteins (Glycoprotein)IBA 11/2023 - 10/2008
5	Blocking AntibodiesIBA 10/2021 - 02/2013
5	Viral RNAIBA 01/2021 - 12/2002
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2015
3	Immunologic Factors (Immunomodulators)IBA 01/2023 - 03/2004
3	Nucleic AcidsIBA 01/2022 - 06/2010
3	Interferon Receptors (Interferon Receptor)IBA 01/2021 - 10/2006
3	Attenuated VaccinesIBA 01/2020 - 01/2017
3	Explosive Agents (Explosives)IBA 01/2018 - 11/2017
3	Indicators and Reagents (Reagents)IBA 09/2007 - 07/2005
2	Caspase 1 (ICE Protease)IBA 04/2024 - 09/2023
2	InflammasomesIBA 04/2024 - 09/2023
2	ChemokinesIBA 10/2023 - 01/2020
2	ProteomeIBA 10/2023 - 01/2018
2	COVID-19 VaccinesIBA 01/2022 - 01/2021
2	oxidized low density lipoproteinIBA 01/2022 - 01/2015
2	IgYIBA 11/2020 - 07/2017
2	Broadly Neutralizing AntibodiesIBA 01/2020 - 05/2017
2	Combined VaccinesIBA 01/2018 - 01/2012
2	PesticidesIBA 01/2017 - 01/2017
2	GlucosidasesIBA 05/2016 - 03/2016
2	Interferon-betaIBA 10/2012 - 03/2004
2	Immunoglobulin A (IgA)IBA 11/2008 - 03/2003
2	Interleukin-10 (Interleukin 10)IBA 10/2008 - 06/2005
1	Syndecan-1 (Syndecan 1)IBA 06/2023
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2023
1	IntegrinsIBA 12/2022
1	cadherin 5IBA 05/2022
1	CateninsIBA 05/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	MucinsIBA 01/2022
1	PlasticsIBA 01/2022
1	GlucansIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2022
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2021
1	Conjugate VaccinesIBA 01/2021
1	Virulence Factors (Pathogenicity Factors)IBA 01/2021
1	SyndecansIBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021

Therapy/Procedure

15	Therapeutics 12/2022 - 12/2002
2	Tourniquets 01/2020 - 01/2012
1	Microspheres (Microsphere) 04/2024
1	Length of Stay 02/2024
1	Lab-On-A-Chip Devices 01/2022
1	Intranasal Administration 01/2022